Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer [NA]

View source ↗

Summary

A recruiting clinical trial evaluating autologous tumor-infiltrating lymphocyte injections (GT201) for adults with advanced lung cancer, sponsored by Grit Biote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• GT201

Snippet

Sponsor: Grit Biotechnology | Conditions: Adult, Lung Cancer | NA | Status: RECRUITING